In these trials, 603 patients were randomised to treatment with Xeloda (1250 mg/ m2 twice daily for 2 weeks followed by a 1-week rest period and given as 3-week cycles).
Ezekben a vizsgálatokban 603 beteget kezeltek Xeloda- val (1250 mg/ m2/ nap 2 hétig, majd 1 hét szünet, 3 hetes ciklusokban adva).